Hors & hers tumbles 27% as the investors that fearlessly uncertainty unsafe drugs composed

Hims & hers (He. He) Stock has expanded 27% on Tuesday after Telealthe Highflier said she can quickly prevents some versions of weight loss drug.

The Fourth of the Company the results of the results of the right is better than expected. But investors were spooked in the loss of potential in the seller of the GLP-1 Blockbuster, which targets diabete and weight loss.

HIMS & HERS CFF YEMI OKEPE DOUREDNED THE ROOKS, saying the weight company constitutes a part of the company’s entry.

“While excited to have 80.000 Suonici’s Specialities for the last year, it is also important to lose other 2 million,” Okoe tells Monday.

Okepe went to highlight the company reported to the company 1.5 billion in revenue for 2024, with $ 1.2 billion other than the glp-1s.

“We have not completely respect all regulatives requirements and, when they believed the shown dose from the platform”, said,

A $ 2.3 billion $ 2.4 billion $ 2,4 billion than high-way consent of $ 2,09 billion. However, the reaction from the Wall Street wall has been cautious.

Since 2022, industry took with a lack of injection products of semaglutides because of a high request.

The year the year, the Hers suspended more than 200% as the successful company, ingredient found in Bockbusster drugs like Novo North As N Nordisk as Novo Novis (Ngo) Ozempic and wegovy.

However, the warehouse killed 26% by its all Friday’s to the United States food administration (fairy) has been resolved and who would make a version of version.

Despite the latest tumble, actions are still 48% year at the date.

Tuesday, Nine Stock Rose 2%. Giant Pharmaceutic Eli Lilly’s (Lly) Actions also purchased after the company has advertised has been cut the cost for their prescription of their glp-1 of their zepbound.

Ines ferre is a senior reporter for Yahoo Finance. Follow her on x to @ines_ferre. I am

Click here for the analysis in depths of the latest news and stock movements of the stock

Read the latest financial news and business news from Yahoo Finance